Abbott Vascular [clinicaltrials_resource:8e3a5abde04275155f38f1e3c8c608e6]
collaborator [clinicaltrials_vocabulary:collaborator]
clinicaltrials:NCT00106938clinicaltrials:NCT00140101clinicaltrials:NCT00148356clinicaltrials:NCT00180310clinicaltrials:NCT00180453PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions [clinicaltrials:NCT00180466]clinicaltrials:NCT00180479Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE [clinicaltrials:NCT00180492]ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries [clinicaltrials:NCT00180505]ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" [clinicaltrials:NCT00180518]Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease [clinicaltrials:NCT00180544]Vision II: Evaluation of GALILEO Intravascular Radiotherapy System [clinicaltrials:NCT00180583]DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) [clinicaltrials:NCT00243438]Frontier Registry II Bifurcation Stent System Registry [clinicaltrials:NCT00286195]Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) [clinicaltrials:NCT00287508]clinicaltrials:NCT00300131CAPTURE 2 Post-Marketing Registry [clinicaltrials:NCT00302237]clinicaltrials:NCT00307047clinicaltrials:NCT00402272clinicaltrials:NCT00402740CHOICE: Carotid Stenting For High Surgical-Risk Patients [clinicaltrials:NCT00406055]A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System [clinicaltrials:NCT00475566]clinicaltrials:NCT00490841XIENCE V: SPIRIT WOMEN [clinicaltrials:NCT00496938]clinicaltrials:NCT00531011The TRIMAXX Coronary Stent Trial [clinicaltrials:NCT00596661]clinicaltrials:NCT00631228clinicaltrials:NCT00676520XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery [clinicaltrials:NCT00731237]RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System [clinicaltrials:NCT00736086]clinicaltrials:NCT00783796clinicaltrials:NCT00844532ABSORB Clinical Investigation, Cohort B [clinicaltrials:NCT00856856]Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period [clinicaltrials:NCT00882219]clinicaltrials:NCT00916370Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France [clinicaltrials:NCT00987506]ABSORB EXTEND Clinical Investigation [clinicaltrials:NCT01023789]XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan [clinicaltrials:NCT01086228]clinicaltrials:NCT01106534clinicaltrials:NCT01115933
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Matt Kiely, Manager Medical Information, Abbott Vascular [clinicaltrials_resource:005f30a259d8a4d67b3d6c5aef8568a8]Matt Kiely, Abbott Vascular [clinicaltrials_resource:26de606f3aab2814bb80a1e01b2c0cd1]Boris Jelecic, Abbott Vascular [clinicaltrials_resource:2d4ba0bdc7633418865ad34d3cba0351]Matt Kiely, Manager, Medical Information, Abbott Vascular [clinicaltrials_resource:6951c95f0b1c421a37466295e1d9540c]Abbott Vascular, Abbott Vascular [clinicaltrials_resource:6cabd12b20290bc0f7837b49ec9ee6b4]Ellen Travis, Abbott Vascular [clinicaltrials_resource:a62b365e3bebecde4e8631103aa4fe09]Kathleen Peeters, Abbott Vascular [clinicaltrials_resource:ab0ee73a881f757bf654bde5f18ccadf]Maureen Kennedy, Abbott Vascular [clinicaltrials_resource:c05d203a26efe3d43114ce28e2580784]Marie-Helene Bettiol, Abbott Vascular [clinicaltrials_resource:fd4d8814f9d83bd89ca34ec1b3cd01a2]
organization [clinicaltrials_vocabulary:organization]
clinicaltrials:NCT00106938clinicaltrials:NCT00140101clinicaltrials:NCT00148356clinicaltrials:NCT00180310clinicaltrials:NCT00180453PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions [clinicaltrials:NCT00180466]clinicaltrials:NCT00180479Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE [clinicaltrials:NCT00180492]ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries [clinicaltrials:NCT00180505]ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" [clinicaltrials:NCT00180518]Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease [clinicaltrials:NCT00180544]Vision II: Evaluation of GALILEO Intravascular Radiotherapy System [clinicaltrials:NCT00180583]DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) [clinicaltrials:NCT00243438]Frontier Registry II Bifurcation Stent System Registry [clinicaltrials:NCT00286195]Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) [clinicaltrials:NCT00287508]clinicaltrials:NCT00300131CAPTURE 2 Post-Marketing Registry [clinicaltrials:NCT00302237]clinicaltrials:NCT00307047clinicaltrials:NCT00402272clinicaltrials:NCT00402740CHOICE: Carotid Stenting For High Surgical-Risk Patients [clinicaltrials:NCT00406055]A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System [clinicaltrials:NCT00475566]clinicaltrials:NCT00490841XIENCE V: SPIRIT WOMEN [clinicaltrials:NCT00496938]clinicaltrials:NCT00531011The TRIMAXX Coronary Stent Trial [clinicaltrials:NCT00596661]clinicaltrials:NCT00631228clinicaltrials:NCT00676520XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery [clinicaltrials:NCT00731237]RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System [clinicaltrials:NCT00736086]clinicaltrials:NCT00783796clinicaltrials:NCT00844532ABSORB Clinical Investigation, Cohort B [clinicaltrials:NCT00856856]Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period [clinicaltrials:NCT00882219]clinicaltrials:NCT00916370Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France [clinicaltrials:NCT00987506]ABSORB EXTEND Clinical Investigation [clinicaltrials:NCT01023789]XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan [clinicaltrials:NCT01086228]clinicaltrials:NCT01106534clinicaltrials:NCT01115933
source [clinicaltrials_vocabulary:source]
Abbott Vascular [clinicaltrials_resource:8e3a5abde04275155f38f1e3c8c608e6]
Bio2RDF identifier
8e3a5abde04275155f38f1e3c8c608e6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8e3a5abde04275155f38f1e3c8c608e6
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:8e3a5abde04275155f38f1e3c8c608e6
title
Abbott Vascular
@en
type
label
Abbott Vascular [clinicaltrials_resource:8e3a5abde04275155f38f1e3c8c608e6]
@en